Ratings Swiss Re Ltd Xetra

Equities

SR9

CH0126881561

Delayed Xetra Other stock markets 11:35:56 2019-06-28 am EDT			5-day change	1st Jan Change
89 ^EUR	+0.23%		-.--%	-.--%

Jul. 08	Swiss Re Unit to Fully Redeem $631 Million of Notes	MT
Jul. 05	SWISS REINSURANCE COMPANY : JP Morgan gives a Buy rating	ZD

Summary

The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
The company is one of the best yield companies with high dividend expectations.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Analyst opinion has improved significantly over the past four months.

Weaknesses

The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Reinsurance

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
SWISS RE LTD	-.--%	35.93B		-
GENERAL INSURANCE CORPORATION OF INDIA	+30.68%	8.67B		-
BROOKFIELD REINSURANCE LTD.	+13.87%	6.53B	-	-
SCOR SE	-2.42%	5.03B		B
ENSTAR GROUP LIMITED	+12.98%	4.73B	-	B
KOREAN REINSURANCE COMPANY	+11.89%	854M		C-
CENTRAL REINSURANCE CORPORATION	+19.09%	665M	-	-
POZAVAROVALNICA SAVA, D.D.	+26.43%	586M	-	-
MNRB HOLDINGS	+90.98%	389M		B-
VIETNAM NATIONAL REINSURANCE CORPORATION	+15.56%	170M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes